Synthetic GLP-1 receptor agonists, like semaglutide or liraglutide, have been shown to effectively lower blood sugar and aid in weight loss
Thats not just a few poundsfor someone weighing 200 pounds, thats potentially 30-40 pounds of sustainable weight loss
It doesnt carry FDA approval as a finished drug product the way brand-name medications do, but for people who cant access or afford brand-name options, it provides a legitimate and accessible path to GLP-1 treatment
Glucagon-like peptide 1: A potential anti-inflammatory pathway in obesity-related asthma
It should only be considered by experienced users who understand and accept these tradeoffs
Related Stories Doctors are using a regulatory gap to prescribe an unauthorized peptide Heat can have adverse effect on people taking certain medications, street drugs Canadians have 1 month left to file claim in class-action drug suit She needs $12K-a-month drug to treat incurable cancer, but insurance wont pay Private clinic Grifols green-lit plasma donors with disease risk, Health Canada finds More from News Video 3:32 WestJet flight attendants go on strike after airline and union fail to reach a deal|Sidhu-1400 Video 4:41 Frustration at Winnipeg airport as WestJet flight attendants strike Video 1:59 WestJet passenger and his family are in St